Search Results - Angela D’Angelo
- Showing 1 - 20 results of 22
- Go to Next Page
-
1
-
2
-
3
Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlle... by Giuseppe, Derosa, Angela, D’Angelo, Davide, Romano, Pamela, Maffioli
Published 2017Text -
4
-
5
A role for quercetin in coronavirus disease 2019 (COVID‐19) by Giuseppe Derosa, Pamela Maffioli, Angela D’Angelo, Francesco Di Pierro
Published 2020Revisão -
6
-
7
-
8
-
9
-
10
Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers by Valeria Brazzelli, Pamela Maffioli, Vittorio Bolcato, Christian Ciolfi, Angela D’Angelo, Carmine Tinelli, Giuseppe Derosa
Published 2021Artigo -
11
-
12
Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells by Valentina Masola, Giovanni Gambaro, Elena Tibaldi, Anna Maria Brunati, Alessandra Gastaldello, Angela D’Angelo, Maurizio Onisto, Antonio Lupo
Published 2011Artigo -
13
Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis by Sandro Giannini, M. Nobile, Leonardo Sartori, Luca Dalle Carbonare, Matteo Ciuffreda, Paolo Corrò, Angela D'Angelo, Lorenzo A. Calò, Gaetano Crepaldi
Published 1999Artigo -
14
Galectin-3 Plasma Levels and Coronary Artery Disease: A New Possible Biomarker of Acute Coronary Syndrome by Colomba Falcone, Simona Lucibello, Iolanda Mazzucchelli, Sara Bozzinì, Angela D’Angelo, Sandra Schirinzi, Rossana Totaro, Rossana Falcone, M. Bondesan, Gabriele Pelissero
Published 2011Artigo -
15
Effects of dietary protein and phosphorus restriction on the progression of early renal failure by Giuseppe Maschio, Lamberto Oldrizzi, Nicola Tessitore, Angela D’Angelo, E. Valvo, Antonio Lupo, C. Loschiavo, Antonia Fabris, Linda Gammaro, Carlo Rugiu, Giovanni Panzetta
Published 1982Artigo -
16
Alendronate Prevents Further Bone Loss in Renal Transplant Recipients by Sandro Giannini, Angela D’Angelo, Gianni Carraro, M. Nobile, Paolo Rigotti, Luciana Bonfante, Francesco Marchini, Martina Zaninotto, Luca Dalle Carbonare, Leonardo Sartori, G Crepaldi
Published 2001Artigo -
17
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone by Giuseppe Derosa, Elena Fogari, Angela D’Angelo, Arrigo F.G. Cicero, Sibilla Salvadeo, P. D. Ragonesi, Ilaria Ferrari, Alessia Gravina, Raffaella Fassi, Roberto Fogari
Published 2007Artigo -
18
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial by Giuseppe Derosa, Luigina Guasti, Angela D’Angelo, Chiara Martinotti, Maria Chiara Valentino, Sergio Di Matteo, Giacomo Matteo Bruno, Andrea Maria Maresca, Giovanni Gaudio, Pamela Maffioli
Published 2022Artigo -
19
Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-.ALPHA. by Giuseppe Derosa, Arrigo F.G. Cicero, Angela D’Angelo, Pietro D. Ragonesi, Leonardina Ciccarelli, Mario N. Piccinni, F. Pricolo, Sibilla Salvadeo, Ilaria Ferrari, Alessia Gravina, Roberto Fogari
Published 2006Artigo -
20
Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome by Giuseppe Derosa, Angela D’Angelo, P. D. Ragonesi, Leonardina Ciccarelli, Mario N. Piccinni, F. Pricolo, Sibilla Salvadeo, Lorenza Montagna, Alessia Gravina, Ilaria Ferrari, S. Paniga, Arrigo F.G. Cicero
Published 2006Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Endocrinology
Diabetes mellitus
Type 2 diabetes
Biochemistry
Body mass index
Chemistry
Gastroenterology
Pathology
Biology
Insulin resistance
Alternative medicine
Antioxidant
Blood pressure
Calcium
Creatinine
Disease
Insulin
Placebo
Resistin
Rosiglitazone
Adipokine
Adiponectin
Cardiology
Coronary artery disease
Gene
Irbesartan
Lipid profile
Metabolic syndrome